Plasma Pen (Plasma MD); Plasma Pen (Plasma +)
FDA 510(k) K223440 · Plasma Concepts
510(k) numberK223440
Submission
- Device name
- Plasma Pen (Plasma MD); Plasma Pen (Plasma +)
- Applicant
- Plasma Concepts
Woburn, MA, US - Received
- November 14, 2022
- Decision date
- March 2, 2023
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
- Summary
- 510(k) summary available from FDA
Device classification
- Product code
- QVJ – Low Power Electrosurgical Devices For Skin Lesion Destruction
- Device class
- Class II (moderate risk)
- Regulation
- 21 CFR 878.4400
- Specialty
- General, Plastic Surgery
For the removal and destruction of skin lesions in general dermatological procedures, also referred to as Plasma Pen Devices, which generates electrical arc in the ambient air between an electrical probe tip and the skin and cause intended tissue damage for the removal and destruction of skin lesions
Other 510(k)s with product code QVJ
Questions and answers
When was Plasma Pen (Plasma MD); Plasma Pen (Plasma +) cleared by the FDA?
Plasma Pen (Plasma MD); Plasma Pen (Plasma +) (K223440) received a 510(k) decision of Substantially Equivalent on March 2, 2023, 108 days after the submission was received.
What is the product code of K223440?
The FDA product code is QVJ – Low Power Electrosurgical Devices For Skin Lesion Destruction, a Class II (moderate risk) device regulated under 21 CFR 878.4400.